XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
Research and development $ 7,806 $ 4,697 $ 19,845 $ 14,054
General and administrative 3,057 1,985 8,612 6,287
Total operating expenses 10,863 6,682 28,457 20,341
Loss from operations (10,863) (6,682) (28,457) (20,341)
Other income (expense):        
Interest and investment income 4 214 231 697
Other expense, net (3) (46) (96) (39)
Total other income, net 1 168 135 658
Net loss $ (10,862) $ (6,514) $ (28,322) $ (19,683)
Net loss per share - basic and diluted (in dollars per share) $ (0.56) $ (0.56) $ (1.59) $ (1.80)
Weighted-average common shares outstanding used in net loss per share - basic and diluted (in shares) 19,424,866 11,624,232 17,769,738 10,945,765